# Regeneron
Latest news and articles about Regeneron
Total: 2 articles found
China’s Biotech Vanguard: Breakthroughs in Lymphoma and Obesity Signal a Shift Toward Global Leadership
China is transitioning from a follower to a leader in biotech, evidenced by Lupin Pharmaceuticals' approval of the first 4th-gen BTK inhibitor and Hansoh Pharma's potent new weight-loss drug. These breakthroughs, supported by massive out-licensing deals with firms like Regeneron, demonstrate that Chinese innovation is now competitive on a global scale.
The 100% Bluff: Why Washington’s Radical Drug Tariff May Never Be Collected
The U.S. government’s announcement of a 100% tariff on imported drugs is essentially a tactical negotiation tool rather than a fiscal reality. Through a series of 'Most Favored Nation' deals and manufacturing incentives, the administration is using the threat of high tariffs to force global drugmakers into domestic investment and lower pricing.